Imperial College London


Faculty of MedicineDepartment of Infectious Disease

Senior Healthcare Research Scientist



+44 (0)20 3313 2732richard.wilson Website




7.S7aCommonwealth BuildingHammersmith Campus





Richard is a clinical pharmacist working in the DHSC Centre for Antimicrobial Optimisation and NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London. His research interests are around ß-lactam PK-PD relationships and individualising antimicrobial therapy with novel technologies.

He is also an antifungal stewardship pharmacist at Imperial College Healthcare NHS Trust.



Arkell P, Wilson R, Antcliffe DB, et al., 2022, A pilot observational study of CSF vancomycin therapeutic drug monitoring during the treatment of nosocomial ventriculitis., Journal of Infection, ISSN:0163-4453

McLeod J, Stadler E, Wilson R, et al., 2021, Electrochemical detection of cefiderocol for therapeutic drug monitoring, Electrochemistry Communications, Vol:133, ISSN:1388-2481

Rawson TM, Wilson R, Moore L, et al., 2021, Exploring the pharmacokinetics of phenoxymethylpenicillin (Penicillin-V) in adults: a healthy volunteer study, Open Forum Infectious Diseases, Vol:8, ISSN:2328-8957, Pages:1-4

Ming DK, Jangam S, Gowers SAN, et al., 2021, Real-time Continuous Measurement of Lactate through a Minimally-invasive Microneedle Biosensor: a Phase I Clinical Study

Rawson TM, Wilson RC, O'Hare D, et al., 2021, Optimizing antimicrobial use: challenges, advances and opportunities, Nature Reviews Microbiology, Vol:19, ISSN:1740-1526, Pages:747-758

More Publications